研究者データベース
櫻井慎太郎 SAKURAI SHINTAROU サクライ シンタロウ
所属部署名： 内科学(内分泌代謝)(壬生) 職名： 病院講師 | |||
Last Updated :2025/04/28
研究業績
論文
- Evaluation of a Premixed Insulin Analog Suspension in Japanese People with Type 2 Diabetes and the Clinical Importance of Improved Injection Techniques: A Cross-Sectional Pilot Study, Suzuki K, Aoki C, Kato K, Shimizu M, Sakurai S, Yanagi K, Kuroda H, Aso Y, Diabetes Ther, 8（2）, 445-449, 2017年04月
- 著明な腫瘍崩壊症候群を呈した造血器腫瘍の３例, 櫻井慎太郎、森田公夫、瀬井恭平、松縄学、岡本翔、森田邦和、川西美里、鈴木達彦、石橋正太、堀賢一郎、渡邉杏子、寺沢智子、成瀬里香、原健二、竹林晃三、麻生好正、犬飼俊彦, 埼玉県医学会雑誌, 47（1）, 52-60, 2012年
- Empagliflozin decreases the plasma concentration of plasminogen activator inhibitor-1 (PAI-1) in patients with type 2 diabetes: Association with improvement of fibrinolysis., Sakurai Shintaro;Jojima Teruo;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, Journal of diabetes and its complications, 34（11）, 107703, 2020年
- Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes., Aso Yoshimasa;Kase Masato;Sagara Masaaki;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Jojima Teruo;Usui Isao, The American journal of the medical sciences, 360（3）, 261-267, 2020年
- Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitors., Iijima Toshie;Hosonuma Soichiro;Kurai Hidetaka;Kajitani Hayato;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, International journal of clinical practice, 75（11）, e14732, 2021年08月19日
- Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis., Sagara Masaaki;Iijima Toshie;Kase Masato;Kato Kanako;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, Journal of diabetes and its complications, 35（5）, 107885, 2021年02月06日
- Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol., Jojima Teruo;Sakurai Shintaro;Wakamatsu Sho;Iijima Toshie;Saito Masahiro;Tomaru Takuya;Kogai Takahiko;Usui Isao;Aso Yoshimasa, International journal of cardiology, 331, 243-248, 2021年02月05日
- Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice., Kishi Haruka;Usui Isao;Jojima Teruo;Fujisaka Shiho;Wakamatsu Sho;Mizunuma-Inoue Yuiko;Niitani Takafumi;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Tobe Kazuyuki;Aso Yoshimasa, International journal of molecular sciences, 23（23）, 2022年12月04日
- Effects of treatment with methimazole on circulating CD4+ and CD8+ T cells positive for programed cell death protein-1 and on subsets of CD4+ T cells in untreated hyperthyroid patients with Graves' disease., Hirao Nanako;Iijima Toshie;Tanuma Dai;Ohira Eriko;Kurai Hidetaka;Shinzawa Toshimitsu;Kase Masato;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, Clinical endocrinology, 97（6）, 841-848, 2022年06月17日
- Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes., Jojima Teruo;Kurai Hidetaka;Tanuma Dai;Kajitani Hayato;Kase Masato;Inoue Yuiko;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, International journal of cardiology. Heart & vasculature, 41, 101071, 2022年06月16日
- Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance., Jojima Teruo;Shinzawa Toshimitsu;Ohira Eriko;Sakurai Shintaro;Tomaru Takuya;Iijima Toshie;Kogai Takahiko;Usui Isao;Aso Yoshimasa, Endocrine journal, 69（8）, 941-945, 2022年03月04日
- Acute Exacerbation of Anemia with Parvovirus B19 Infection One Year after Sleeve Gastrectomy for Severe Obesity., Shinzawa Toshimitsu;Usui Isao;Hanawa Kanako;Kajitani Hayato;Sakurai Shintaro;Tomaru Takuya;Iijima Toshie;Jojima Teruo;Kojima Kazuyuki;Aso Yoshimasa, Internal medicine (Tokyo, Japan), 61（17）, 2631-2635, 2022年02月08日
- Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor., Wakamatsu Sho;Jojima Teruo;Hashiguchi Masaaki;Kishi Haruka;Niitani Takafumi;Sakurai Shintaro;Iijima Toshie;Kogai Takahiko;Tomaru Takuya;Usui Isao;Aso Yoshimasa, Journal of diabetes and its complications, 38（1）, 108650, 2023年11月23日
原著論文
- Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report., Jojima Teruo;Kogai Takahiko;Iijima Toshie;Kato Kanako;Sagara Masaaki;Kezuka Atsumi;Kase Masato;Sakurai Shintaro;Akimoto Kazumi;Sakumoto Junko;Namatame Takashi;Ueki Keisuke;Hishinuma Akira;Kamai Takao;Usui Isao;Aso Yoshimasa, European journal of endocrinology, 183（6）, K7-K12, 2020年12月
- Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication., Shinohara Yasutake;Iijima Toshie;Sakurai Shintaro;Jojima Teruo;Ohira Eriko;Hayashi Shujiro;Usui Isao;Igawa Ken;Aso Yoshimasa, Clinical case reports, 8（10）, 2007-2012, 2020年10月
症例報告
- 2型糖尿病患者におけるシタグリプチンとグリメピリドの血管内皮機能についてのブドウ糖負荷時の急性効果と慢性効果の比較検討, 櫻井 慎太郎;城島 輝雄;相良 匡昭;柳 一徳;飯嶋 寿江;薄井 勲;麻生 好正, 糖尿病, 62（Suppl.1）, S-254, 2019年04月
- Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetes., Kase Masato;Iijima Toshie;Niitani Takafumi;Sagara Masaaki;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, Diabetology international, 14（1）, 94-102, 2022年09月29日
不明